Result of Meeting
RNS Number : 7857S
Schiehallion Fund Limited (The)
18 March 2021
 

The Schiehallion Fund Limited

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

 

18 March 2021

Results of Extraordinary General Meeting

 

The Schiehallion Fund Limited (the "Company") is pleased to announce that, at an extraordinary general meeting of the Company held earlier today, a resolution to grant the directors of the Company a general authority to allot, without regard to the pre-emption rights contained in the articles of incorporation of the Company, up to 700 million C Shares (as defined in the articles of incorporation of the Company), such authority to expire on 31 December 2021. as set out in the circular to shareholders dated 25 February 2021, was duly approved by shareholders.

Details of the proxy votes lodged before the extraordinary general meeting, which should be read alongside the notice contained in the Circular will be available shortly at www.schiehallionfund.com.

A copy of the resolution passed at the extraordinary general meeting has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fac.org.uk/#/nsm/nationalstoragemechanism.

 

Baillie Gifford & Co Limited

18 March 2021

For further information please contact:

Alex Blake, Baillie Gifford & Co

Tel: 0131 275 2859

 

 

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws and regulations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFSDVTITLIL